Skip to content

PHARMA SERVICES

Absorbed by GESTIFAR KBO/BCE: BE 0471.348.140 subsidiary of ETABLISSEMENT VANDERELST SRL

Last board

1 director, last change in 2021
Sole director
since 30-09-2015
listed in the 2021 annual accounts, filed on 28-06-2022

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
Gestifar
Sole director
Jean-Christophe Vanderelst
Sole director
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • Gestifar
    • Sole director, from 30-09-2015 to date
  • Jean-Christophe Vanderelst
    • Sole director, from before 01-07-2021, no longer listed in the 2021 annual accounts

Control

Consolidating parent
Equity €444,329
Profit €458 in 2025 (profit €8,174 in 2024)
Checked score 70
consolidates
This company
PHARMA SERVICES
Equity €97,910
Loss €332 in 2021

Capital

Contribution
€18,550
Shares
1,251
Contribution per share
€14.83
Equity per share
€78.27 in 2021
Source
2021 annual accounts

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 01-07-2021 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

Capital transactions

Shareholders according to the deeds
At incorporation deed of 01-07-2021 ↗
  • Gestifar (BE 0441.670.890) sole founder · 100% at incorporation
Capital over time
  1. 01-07-2021 Incorporation · €31,011.48 · 1,251 shares
  2. 01-07-2021 Incorporation · €61,973.38 · 250 shares
  3. 01-07-2021 Capital increase of €156,065.39 · to €218,038.77 · 630 new shares · in kind
  4. 01-07-2021 Capital reduction of €108,038.77 · to absorb losses
  5. 01-07-2021 Capital reduction of €91,450 · repaid to the shareholders

Next steps